Samsung Bioepis

INCHEON, South Korea & KIRKLAND, Quebec, Canada, June 18, 2026 Samsung Bioepis and Organon have expanded their long-standing biosimilar...

INCHEON, South Korea, May 20, 2026 Samsung Bioepis has announced the official launch of Ustekinumab BS 45 mg Syringe...

INCHEON, South Korea, March 16, 2026 Samsung Bioepis Co., Ltd. and Epis NexLab Co., Ltd. have announced a strategic...